Moreover, compared with 50 normal hepatic samples, SOCS2 in HCC stage IV was lower than that in stage I, II and III (Fig. 1H), which was in consistent with the phenomenon that patient of low SOCS2 expression possessed a poor prognosis. Here, SOCS2 is linked to hepatocellular carcinoma.